Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q4 FY20 results · Jan–Mar 2020
Advanced Enzyme Technologies reported revenue from operations of ₹110.26 crore (down 0.1% from Q4 FY19) and net profit of ₹32.68 crore (down 2.3% from Q4 FY19) for Q4 FY20 (Jan–Mar 2020), on a consolidated basis.
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 110.26 | 110.42 | −0.1% | 111.94 | −1.5% |
| Other income | 1.84 | 2.64 | −30.1% | 1.21 | +52.9% |
| Total income | 112.11 | 113.05 | −0.8% | 113.15 | −0.9% |
| Profit before tax | 43.20 | 46.48 | −7.1% | 46.89 | −7.9% |
| Net profit for the period | 32.68 | 33.46 | −2.3% | 34.56 | −5.4% |
| Attributable to shareholders of the company | 31.33 | 32.21 | −2.7% | 33.60 | −6.8% |
| EPS, basic (₹) | 2.81 | 2.89 | −2.8% | 3.01 | −6.6% |
| Net margin (%) | 29.6 | 30.3 | 30.9 |
| Item | Q4 FY20 | Q4 FY19 | YoY | Q3 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 68.42 | 55.93 | +22.3% | 61.51 | +11.2% |
| Other income | 1.29 | 1.79 | −27.8% | 4.97 | −74.1% |
| Total income | 69.71 | 57.72 | +20.8% | 66.48 | +4.9% |
| Profit before tax | 21.60 | 12.59 | +71.6% | 21.80 | −0.9% |
| Net profit for the period | 16.00 | 9.15 | +74.9% | 17.53 | −8.7% |
| EPS, basic (₹) | 1.43 | 0.82 | +74.4% | 1.57 | −8.9% |
| Net margin (%) | 23.4 | 16.4 | 28.5 |
Consolidated
- Filed with BSE
- 30 May 2020, 20:13 IST
- Board meeting
- 30 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 May 2020, 20:13 IST
- Board meeting
- 30 May 2020
- Period
- 01 Jan 2020 to 31 Mar 2020
- Review status
- Audited
- Source
- XBRL filing on BSE